NCT00108745

Clinical Trial Information


Trial Number: NCT00108745 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103(IND# 70177) Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy
Study ID:
GOG-0212
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00108745-D4 This dataset contains maximum grade adverse events by preferred term from trial NCT00108745 presented in 35759733. NCT00108745-D1 contains patient characteristics and outcome data. NCT00108745-D2 contains QOL data. NCT00108745-D3 contains adverse event data by organ system.
NCT00108745-D3 This dataset contains maximum grade adverse events from trial NCT00108745 presented in 35759733. NCT00108745-D1 contains patient characteristics and outcome data. NCT00108745-D2 contains QOL data. NCT00108745-D4 contains adverse event data by preferred term.
NCT00108745-D2 This dataset contains quality of life (QOL) data from trial NCT00108745 presented in 35759733. NCT00108745-D1 contains patient characteristics and outcome data. NCT00108745-D3 contains adverse event data by organ system. NCT00108745-D4 contains adverse event data by preferred term.
NCT00108745-D1 This dataset contains the data from the treatment comparison between 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103(IND# 70177) Versus No Treatment in trial NCT00108745. NCT00108745-D2 contains QOL data. NCT00108745-D3 contains adverse event data by organ system. NCT00108745-D4 contains adverse event data by preferred term.